EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Differences between SARS-CoV-2 and RSV Infections in Infants: Findings from a Case–Control Study

Victor Daniel Miron iD, Raluca-Oana Raianu, Claudiu Filimon, Mihai Craiu iD

Viruses · 2023

DOI: 10.3390/v16010063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Victor Daniel Miron und 3 weiteren Autor:innen. Beteiligte Einrichtung: Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: COVID-19, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infants are a unique pediatric group due to their high hospitalization rates and unfavorable outcomes from acute infectious diseases. Understanding the clinical differences and aftereffects of SARS-CoV-2 in comparison to other prevalent viruses in this age group, like RSV, is crucial for effective management. We conducted a retrospective case–control study of infants hospitalized with SARS-CoV-2 or respiratory syncytial virus (RSV) infection in one year, in a tertiary pediatric hospital in Bucharest, Romania. A total of 188 infants were included in the analysis in a 1:1 ratio (94 with SARS-CoV-2 infection and 94 with RSV infection). Infants with COVID-19 were 10.2 times more likely to have fever (p < 0.001) and 2.4 times more likely to have diarrhea (p = 0.016). Conversely, infants with RSV were 2.5 times more likely to have a cough (p < 0.001), 3.0 times more likely to have nasal congestion (p < 0.001), and 14.7 times more likely to present with dyspnea (p < 0.001). Increased lymphocyte count was more common in infants with RSV (p = 0.008), while lymphopenia was more frequent in infants with SARS-CoV-2 (p = 0.011). The median length of hospital stay was one day longer in infants with RSV infection (5 days vs. 4 days). Overall, infants with RSV infection had a 27.3-fold increased risk of developing respiratory failure (p < 0.001), while infants with COVID-19 had a 5.8-fold increased risk of laryngitis (p = 0.003). Our findings suggest that infants with SARS-CoV-2 infection may present with polymorphic symptoms, mostly dominated by fever, whereas infants with RSV often present with respiratory symptoms. Laboratory differentiation between the two infections is challenging; therefore, the use of rapid antigen or molecular diagnostic tests is crucial for accurate diagnosis, epidemiologically appropriate measures, and effective management. Continued surveillance of both viruses in infants, and beyond, and the implementation of specific control measures are needed to mitigate their impact on this vulnerable pediatric group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Syncytial Virus InfectionsInfantHumansChildSARS-CoV-2Case-Control StudiesRetrospective StudiesFever

Stichwörter der Autor:innen

COVID-19RSVSARS-CoV-2clinical featuresinfantlaryngitisrespiratory failure

Autor:innen und Institutionen

  • Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • National Institute for Mother and Child Health "Alessandrescu-Rusescu", 020395 Bucharest, Romania.

ORCID-Profile: Victor Daniel Miron, Mihai Craiu

Zitieren

APA

Miron, V. D., Raianu, R. O., Filimon, C., & Craiu, M. (2023). Clinical Differences between SARS-CoV-2 and RSV Infections in Infants: Findings from a Case–Control Study. Viruses. https://doi.org/10.3390/v16010063

Vancouver

Miron VD, Raianu RO, Filimon C, Craiu M. Clinical Differences between SARS-CoV-2 and RSV Infections in Infants: Findings from a Case–Control Study. Viruses. 2023. doi:10.3390/v16010063

BibTeX
@article{Miron2023,
  author = {Miron, Victor Daniel and Raianu, Raluca-Oana and Filimon, Claudiu and Craiu, Mihai},
  title = {Clinical Differences between SARS-CoV-2 and RSV Infections in Infants: Findings from a Case–Control Study},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v16010063}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche